Dr David Spigel talks about currently available and emerging biomarkers that predict the greatest sensitivity to immunotherapy, including his insight into PD-L1, MSI, and TMB.
Related Items
2020 Year in Review - Lung Cancer published on January 20, 2021 in Lung Cancer
2020 Year in Review - Lung Cancer published on January 20, 2021 in Lung Cancer
Last modified: April 27, 2020